课题基金 / 基金详情

Postdoctoral Training in Medical Genetics

Postdoctoral Training in Medical Genetics
医学遗传学博士后培训
批准号:
6561113
负责人:
SEYMOUR PACKMAN
金额:
$16.57万
依托单位国家:
美国
项目类别:
财政年份:
1975
资助国家:
美国
项目状态:
已结题
起止时间:
1975-07-01 至 2008-06-30

项目摘要

项目成果

SEYMOUR PACKMAN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):我们提出了一个博士后项目,提供医学遗传学的研究培训。该计划的主要目标是培训医学遗传学研究的医生,使他们能够成为独立的调查人员,以及人类遗传疾病的学术和科学领导者。该计划的一个特殊和独特的优势是UCSF医学遗传学的临床和研究活动的整合,导致研究学员与临床遗传学的学员和教师的互动。因此,研究培训人员提供了最广泛的背景,在此基础上制定和发展未来的研究问题。培训计划的主要组成部分(约80%)是在计划学院调查员的监督下进行明确定义的实质性研究项目。培训学院包括来自临床和基础科学部门的研究人员。培训学院的研究活动是真正多样化的,包括基础,临床实验室和流行病学研究:生物化学遗传学、癌症遗传学、心血管发育遗传学、胎儿发育和出生缺陷、基因治疗、复杂疾病遗传学、耳聋遗传学、遗传性皮肤病、基因组学和信息学、血红蛋白病、免疫遗传学、肝病、脂蛋白疾病、分子细胞遗传学、药理遗传学、性染色体生物学和哺乳动物、果蝇和斑马鱼发育遗传学。该培训计划的教师在遗传学的博士前和博士后培训方面有着出色的记录,令人印象深刻的实验室设施,以及为他们的研究提供的广泛资金。因此,该学院可以提供空间,实验室资源和计划环境,为博士后学员在该计划下的成功研究培训。培训计划的其他组成部分包括出席预定的研究和医学遗传学会议;研究方法和基础遗传学和高级人类遗传学的研究生课程;以及临床和临床实验室遗传学的有针对性的指导。绝大多数申请人和参赛者是医生(MD或MD-Ph.D.)对医学遗传学的研究事业感兴趣。该计划还能够容纳科学家(博士)对医学遗传学的研究、教学和临床实验室工作感兴趣。该计划是由一个项目主任和一个咨询小组,谁定期评估和监测学员的进展在加州大学旧金山分校监督。最后,该计划将从目前对UCSF人类遗传学学术存在的广泛扩展和增强的承诺中受益匪浅。
英文摘要
DESCRIPTION (provided by applicant): We propose a postdoctoral Program to provide research training in medical genetics. The primary objective of the program is the training of physicians in research in medical genetics, to enable them to become independent investigators, and academic and scientific leaders in human genetic disease. An especial and unique strength of the Program is the integration of clinical and research activities in medical genetics at UCSF, resulting in the interactions of research trainees with trainees and faculty in clinical genetics. Research trainees are thereby provided with the broadest possible background upon which to formulate and develop future research problems. The major component (about 80%) of the Training Program is the conduct of a clearly defined and substantive research project under the supervision of a Program Faculty investigator. The Training Faculty includes investigators from both clinical and basic science departments. The research activities of the Training Faculty are truly diverse, and include basic, clinical laboratory, and epidemiologic research in: biochemical genetics, cancer genetics, cardiovascular developmental genetics, fetal development and birth defects, gene therapy, the genetics of complex disorders, the genetics of deafness, genodermatoses, genomics and informatics, hemoglobinopathies, immunogenetics, liver disease, lipoprotein disorders, molecular cytogenetics, pharmacogenetics, sex chromosome biology, and mammalian, Drosophila and zebra fish developmental genetics. Faculty members of this Training Program have an excellent record in pre-and post-doctoral training in genetics, impressive laboratory facilities, and extensive funding for their research. This faculty can therefore provide the space, laboratory resources, and programmatic environments for the successful research training of postdoctoral trainees under this Program. Additional components of the Training Program include attendance at scheduled research and medical genetics conferences; graduate level courses in research methodology and in basic genetics and advanced human genetics; and targeted instruction in clinical and clinical laboratory genetics. The vast majority of applicants and entrants are physicians (MD or MD-Ph.D.)) interested in research careers in medical genetics. The Program has also been able to accommodate scientists (Ph.D.) interested in research, teaching, and clinical laboratory careers in medical genetics. The Program is overseen at UCSF by a Program Director and an Advisory Group, who regularly evaluates and monitors the progress of trainees. Finally, the Program will immeasurably benefit from the current commitment to the broad expansion and enhancement of the academic presence of human genetics at UCSF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL INVESTIGATION OF THE PATIENT WITH INBORN ERROR OF METABOLISM
MULTI-CENTER, OPEN LABEL OF FABRAZYME IN PATIENTS WITH FABRY DISEASE
Safety and efficacy of recombinant human alpha-galactosidase A
Multi-center, open label of Fabrazyme in patients with Fabry disease
海外基金